• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者透析前收缩压与脉搏率联合评估对1年全因死亡率和心血管死亡率的影响:一项全国性队列研究

Combined pre-dialysis systolic blood pressure and pulse rate assessment for 1-year all-cause and cardiovascular mortality in patients on hemodialysis: a nationwide cohort study.

作者信息

Joki Nobuhiko, Toida Tatsunori, Niihata Kakuya, Inanaga Ryohei, Nakata Kenji, Abe Masanori, Hanafusa Norio, Kurita Noriaki

机构信息

Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan.

The Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.

出版信息

Hypertens Res. 2025 May 19. doi: 10.1038/s41440-025-02231-x.

DOI:10.1038/s41440-025-02231-x
PMID:40389635
Abstract

The prognostic utility of the combined assessment of pre-hemodialysis systolic blood pressure (SBP) and pulse rate compared to their independent assessment is unclear. In this nationwide cohort study, we aimed to determine whether their combined assessment could enhance the prognostic utility in patients on maintenance hemodialysis using the Japanese Renal Data Registry database. Exposure was defined as a combination of SBP and pulse rate. Forty-eight levels of exposure groups were created: SBP (<100, 100- < 120, 120- < 140, 140- < 160 [reference], 160- < 180, and ≥180 mmHg) and pulse rate (<50, 50- < 60, 60- < 70 [reference], 70- < 80, 80- < 90, 90- < 100, 100- < 110, and ≥110 beats/min). The primary and secondary outcomes were 1-year all-cause and cardiovascular mortalities, respectively. Multivariate Cox proportional hazards models were used, and multiplicative and additive interactions were assessed. The combined model for mortality and cardiac mortality was statistically better than the separate SBP and pulse rate model. Lower SBP was associated with higher risk of all-cause mortality irrespective of pulse rate. Most categories of lower SBP or higher pulse rate vs. the 120- < 140 mmHg and 70- < 80 beats/min category had positive relative excess risk due to interactions, with similar findings observed for cardiac mortality. Combined assessment of pre-dialysis SBP and pulse rate may help the simple stratification of patients with excess risks that cannot be identified by separate SBP and pulse rate assessment.

摘要

与单独评估相比,血液透析前收缩压(SBP)和脉搏率联合评估的预后效用尚不清楚。在这项全国性队列研究中,我们旨在利用日本肾脏数据登记数据库确定其联合评估是否能提高维持性血液透析患者的预后效用。暴露定义为SBP和脉搏率的组合。创建了48个暴露组:SBP(<100、100 - <120、120 - <140、140 - <160[参考值]、160 - <180和≥180 mmHg)和脉搏率(<50、50 - <60、60 - <70[参考值]、70 - <80、80 - <90、90 - <100、100 - <110和≥110次/分钟)。主要和次要结局分别为1年全因死亡率和心血管死亡率。使用多变量Cox比例风险模型,并评估相乘和相加交互作用。死亡率和心脏死亡率的联合模型在统计学上优于单独的SBP和脉搏率模型。无论脉搏率如何,较低的SBP与较高的全因死亡风险相关。与120 - <140 mmHg和70 - <80次/分钟组相比,大多数较低SBP或较高脉搏率组由于交互作用具有正的相对超额风险,心脏死亡率也有类似发现。透析前SBP和脉搏率的联合评估可能有助于对单独的SBP和脉搏率评估无法识别的高风险患者进行简单分层。

相似文献

1
Combined pre-dialysis systolic blood pressure and pulse rate assessment for 1-year all-cause and cardiovascular mortality in patients on hemodialysis: a nationwide cohort study.血液透析患者透析前收缩压与脉搏率联合评估对1年全因死亡率和心血管死亡率的影响:一项全国性队列研究
Hypertens Res. 2025 May 19. doi: 10.1038/s41440-025-02231-x.
2
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.
3
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Blood pressure targets for hypertension in people with chronic renal disease.高血压合并慢性肾脏病患者的血压目标。
Cochrane Database Syst Rev. 2024 Oct 15;10(10):CD008564. doi: 10.1002/14651858.CD008564.pub3.
6
Pharmacotherapy for hypertension in adults aged 18 to 59 years.18至59岁成年人高血压的药物治疗
Cochrane Database Syst Rev. 2017 Aug 16;8(8):CD008276. doi: 10.1002/14651858.CD008276.pub2.
7
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
8
Higher blood pressure targets for hypertension in older adults.老年人高血压的更高血压目标
Cochrane Database Syst Rev. 2024 Dec 17;12(12):CD011575. doi: 10.1002/14651858.CD011575.pub3.
9
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Chronic Hypotension and Transplant Outcomes-the Known Unknowns.慢性低血压与移植结局——已知的未知因素
Kidney Int Rep. 2024 May 7;9(6):1571-1573. doi: 10.1016/j.ekir.2024.04.065. eCollection 2024 Jun.
2
Prognostic Value of Nighttime Double Product in Nondialysis Chronic Kidney Disease With Hypertension.夜间双乘积在高血压非透析慢性肾脏病中的预后价值。
J Am Heart Assoc. 2023 Dec 19;12(24):e031627. doi: 10.1161/JAHA.123.031627. Epub 2023 Dec 18.
3
Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study.
心率血压乘积作为经皮冠状动脉介入治疗后患者长期不良结局的新预测因子:一项回顾性队列研究。
BMJ Open. 2023 Apr 4;13(4):e067951. doi: 10.1136/bmjopen-2022-067951.
4
Why is Intradialytic Hypotension the Commonest Complication of Outpatient Dialysis Treatments?为何透析中低血压是门诊透析治疗最常见的并发症?
Kidney Int Rep. 2022 Nov 10;8(3):405-418. doi: 10.1016/j.ekir.2022.10.031. eCollection 2023 Mar.
5
Association of Four Types of Vascular Access Including Arterial Superficialization with Mortality in Maintenance Hemodialysis Patients: A Nationwide Cohort Study in Japan.四种血管通路类型(包括动脉浅表化)与维持性血液透析患者死亡率的关系:日本全国队列研究。
Am J Nephrol. 2023;54(3-4):83-94. doi: 10.1159/000529991. Epub 2023 Mar 14.
6
Blood pressure, heart rate, or the Rate Pressure Product: what is the best predictor of clinical outcome?血压、心率还是心率血压乘积:哪项是临床预后的最佳预测指标?
Eur Heart J Open. 2022 Oct 5;2(5):oeac063. doi: 10.1093/ehjopen/oeac063. eCollection 2022 Sep.
7
Using Causal Diagrams to Improve the Design and Interpretation of Medical Research.使用因果关系图改进医学研究的设计与解读
Chest. 2020 Jul;158(1S):S21-S28. doi: 10.1016/j.chest.2020.03.011.
8
Utility of shock index in 24,636 patients presenting with acute coronary syndrome.在 24636 例急性冠状动脉综合征患者中,休克指数的应用。
Eur Heart J Acute Cardiovasc Care. 2020 Sep;9(6):546-556. doi: 10.1177/2048872619886307. Epub 2019 Nov 8.
9
The Interaction Continuum.互动连续统。
Epidemiology. 2019 Sep;30(5):648-658. doi: 10.1097/EDE.0000000000001054.
10
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study (J-DOPPS).在血液透析患者中,以自我报告的能量水平衡量的活力与临床结局:日本透析结局和实践模式研究(J-DOPPS)。
Am J Kidney Dis. 2019 Apr;73(4):486-495. doi: 10.1053/j.ajkd.2018.10.001. Epub 2018 Dec 7.